Sun Pharma's subsidiary launches Ilumya in Japan

Ilumya Subcutaneous Injection 100 mg Syringe (tildrakizumab) will be used for treatment of Plaque Psoriasis.

from India Infoline News Service https://ift.tt/3j8FLxH